Pharming Group NV (PHAR)
17.60
+0.12
(+0.69%)
USD |
NASDAQ |
Dec 11, 16:00
17.60
0.00 (0.00%)
After-Hours: 18:49
Pharming Group Total Liabilities (Quarterly): 209.14M for Sept. 30, 2025
Total Liabilities (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Total Liabilities Definition
Liabilities are a main portion of the balance sheet of a company that measure outstanding payables/obligations. A few examples of liabilties of a company include accounts payable, current debt, and capital lease obligations. From an accounting perspective, the balance sheet equation is Liabilties = Assets - Shareholder's Equity.
Total Liabilities (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Total Liabilities (Quarterly) Benchmarks
| CorMedix, Inc. | 376.73M |
| uniQure NV | 659.64M |
| Kiniksa Pharmaceuticals International Plc | 176.95M |
| ProQR Therapeutics NV | 79.05M |
| Merus NV | 129.26M |
Total Liabilities (Quarterly) Related Metrics
| Total Assets (Quarterly) | 473.78M |
| Shareholders Equity (Quarterly) | 264.64M |
| Debt to Equity Ratio | 0.4947 |
| Current Ratio | 3.158 |
| Net Debt Paydown Yield | 0.04% |